20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis

Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1359-67. doi: 10.1152/ajpheart.00802.2014. Epub 2015 Mar 27.

Abstract

Endothelial cells play an important role in the process of coagulation and the function of platelets. We have previously reported that 20-hydroxyeicosatetraenoic acid (20-HETE), a metabolite of arachidonic acid, increased platelet aggregation and induced hemostasis. The purpose of the present study is to investigate whether 20-HETE-mediated endothelial activation has effect on the coagulation and platelet aggregation. C57Bl/6 mice were treated with PBS or 20-HETE (20 μg/kg) for 2 h, and then we performed a carotid artery or femoral artery thrombosis model by FeCl3. Detection of blood flow indicated that 20-HETE pretreatment accelerated formation of thrombus in both common carotid artery and femoral artery. In vitro, the secretion and expression of von Willebrand factor (vWF) in cultured human umbilical vein endothelial cells (HUVECs) with 20-HETE stimulation were increased, subsequently. The protein level of vWF in HUVECs was decreased at 1 h but increased with prolonged treatment with 20-HETE (>4 h). In contrast, vWF in the culture medium was increased under administration of 20-HETE at 1 h. As a result, adhesion of platelets on HUVECs was significantly increased by 20-HETE. In HUVECs, the extracellular signal-regulated kinase (ERK) pathway was activated by 20-HETE in a dose-dependent manner, and the inhibitors of ERK and L-type Ca(2+) channel blocked the release of vWF mediated by 20-HETE. In conclusion, 20-HETE instigates endothelial activation and induces the expression and secretion of vWF via the activation of ERK and calcium channel and therefore triggers thrombosis.

Keywords: 20-HETE; endothelial cells; von Willebrand factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Coagulation / drug effects
  • Calcium Channel Blockers / pharmacology
  • Carotid Arteries / drug effects
  • Carotid Arteries / physiopathology
  • Femoral Artery / drug effects
  • Femoral Artery / physiopathology
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Hydroxyeicosatetraenoic Acids / pharmacology*
  • MAP Kinase Signaling System
  • Mice
  • Mice, Inbred C57BL
  • Platelet Aggregation / drug effects
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Thrombosis / blood*
  • Thrombosis / metabolism
  • von Willebrand Factor / genetics
  • von Willebrand Factor / metabolism

Substances

  • Calcium Channel Blockers
  • Hydroxyeicosatetraenoic Acids
  • Protein Kinase Inhibitors
  • von Willebrand Factor
  • 20-hydroxy-5,8,11,14-eicosatetraenoic acid